West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 404,200 | 484,600 | 490,900 | 446,200 | 601,800 |
| Receivables | 543,600 | 552,500 | 524,300 | 479,400 | 524,000 |
| Inventories | 388,700 | 377,000 | 401,200 | 419,200 | 429,900 |
| Other current assets | 121,000 | 124,000 | 134,200 | 138,200 | 137,200 |
| TOTAL | $1,457,500 | $1,538,100 | $1,550,600 | $1,483,000 | $1,692,900 |
| Non-Current Assets | |||||
| PPE Net | 1,631,700 | 1,581,600 | 1,571,000 | 1,493,700 | 1,448,600 |
| Investments And Advances | 211,900 | 202,100 | 217,500 | 198,200 | 202,500 |
| Intangibles | 117,500 | 116,800 | 121,100 | 120,200 | 121,500 |
| Other Non-Current Assets | 199,600 | 204,800 | 214,900 | 194,300 | 136,800 |
| TOTAL | $2,160,700 | $2,105,300 | $2,124,500 | $2,006,400 | $1,909,400 |
| Total Assets | $3,618,200 | $3,643,400 | $3,675,100 | $3,489,400 | $3,602,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 228,400 | 239,300 | 224,300 | 211,700 | 240,100 |
| Accrued Expenses | 67,800 | 73,500 | 79,600 | 82,900 | 66,500 |
| Other current liabilities | 186,400 | 188,200 | 159,300 | 169,000 | 173,600 |
| TOTAL | $526,700 | $550,400 | $516,500 | $633,700 | $648,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 202,600 | 202,600 | 202,600 | 72,900 | 72,800 |
| Other Non-Current Liabilities | 173,100 | 172,200 | 179,300 | 176,800 | 169,200 |
| TOTAL | $408,400 | $410,700 | $406,500 | $278,900 | $273,300 |
| Total Liabilities | $935,100 | $961,100 | $923,000 | $912,600 | $921,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,845 | 72,304 | 72,422 | 72,542 | 72,843 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 4,031,200 | 3,956,600 | 3,856,900 | 3,720,900 | 3,624,100 |
| Other shareholders' equity | -205,700 | -258,200 | -135,900 | -216,400 | -192,500 |
| TOTAL | $2,683,100 | $2,682,300 | $2,752,100 | $2,576,800 | $2,680,600 |
| Total Liabilities And Equity | $3,618,200 | $3,643,400 | $3,675,100 | $3,489,400 | $3,602,300 |